WAO Guidelines | AAAAI/ACAAI Guidelines | EAACI Guidelines | |
---|---|---|---|
Symptoms and signs (typically within minutes to hours after exposure; multi-system; rapid progression) | describe symptoms and signs in detail; Table 2 | describe symptoms and signs; list frequency of symptoms and signs in different organ systems; Table E1 | describe symptoms and signs; Figure 1 |
Clinical criteria for diagnosis of anaphylaxis | primary emphasis on clinical diagnosis; clinical criteria for diagnosis are listed and illustrated; Table 1, Figure 3 | primary emphasis on clinical diagnosis: state “the history is the most important tool”; clinical criteria for diagnosis are listed; Figure E1 | primary emphasis on clinical diagnosis: clinical criteria for diagnosis are listed; Box 4 |
Laboratory tests for confirmation of the clinical diagnosis | describe use of tryptase or histamine measurements and other tests in a supportive role; emphasize correct timing of blood samples; Table 3 | describe use of tryptase or histamine measurements and other tests in a supportive role; emphasize correct timing of blood samples; Table E3 | describe use of tryptase measurements in a supportive role |
Differential diagnosis | comprehensive list provided; additional laboratory tests for ruling out other diagnoses are described; Table 4 | comprehensive list provided; additional laboratory tests for ruling out other diagnoses are described; Tables E2, E3 | comprehensive list provided, including detailed list of neuropsychiatric diseases; Box 5 |
Diagnosis of anaphylaxis in special populations | include reference ranges for vital signs in infants and children, and discuss relevant clinical and lab issues in infants, pregnant women and the elderly; Figure 1 | include normal values for vital signs in infants and children; Table E4 | describe patient-specific factors: examples include adolescence, advanced age, and gender; Box 6 |